Did you miss our recent webinar exploring gene therapies for Parkinson’s Disease?
Watch the full recording here: https://t.co/lPIw5hM83a
#ParkinsonsDisease#GeneTherapy
It's critical to incorporate patient safety and the patient perspective into the study design when developing a long-term follow-up strategy for a gene therapy trial. Read our experts' latest article in
@IntClinTrials. https://t.co/0RW1IXSOy1
Designing and conducting a #GeneTherapy trial is a complex undertaking. Read our latest blog exploring critical study design considerations of gene therapy trials and strategies for overcoming patient enrollment and safety challenges. https://t.co/bK2e3bjJHj
The global pandemic has exacerbated the challenges intrinsic to gene therapy trials. Read our blog highlighting strategies to ensure your trial’s operational efficiency and patient centricity. https://t.co/2FxHlgA6Bf #GeneTherapy
“Rare disease research provides hope to patients and families that are often overlooked. It gives them options and a way forward that would otherwise not have been there.” – Hanna Wide, Executive Director, Cell and Gene Therapy, Premier Research
#RareDiseaseDay
@DouglassUla@shoegalhelsinki@ChrChristensen There hasn't been enough education in Sweden on how or why to where masks. Swedes do follow rules, but they have to make sense to them at the time.
For a condition that afflicts just one in 31,000 people, recruiting even 18 patients is a challenge. That's when we got creative. �� Case Study: From KOLs to Patient Advocates, Using Every Tool to Fight a Rare Disease https://t.co/KAXe9JtGQh
Looking for a CRO to conduct your next rare disease study? Come speak to the experts at Premier Research, booth #22, and find out how we can help put your next trial on the path towards success! #WODCEU
Have you signed up to the #RareDiseaseDay 2018 thunderclap campaign? On 28 February a message in support of the rare disease community will be shared on the social media accounts of everyone who joins! https://t.co/8USTc1oz0f #ShowYourRare @RareDiseases@raredisorders @RareVoices